Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.
SB 3 creates a Prescription Drug Affordability Board to establish maximum payment limits for certain prescription drugs, including brand-name, generic, biologic, and biosimilar medications. The Board, appointed by the governor with health care expertise, will review drug costs and set these limits to improve affordability for Michigan residents. It also establishes a Prescription Drug Affordability Stakeholder Council to provide input and a fund to support the program. This law directly affects drug manufacturers, health insurers, pharmacy benefit managers, and state agencies by requiring adherence to the set payment limits.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2025
Committee Review
Apr 2025
Senate Passage
Apr 2025
House Passage
Governor
Introduced Jan 8, 2025
Last action Apr 24, 2025
Maddy AI version diff · 2 comparisons
What changed between versions
As Passed by the Senate
→
Substitute (S-1)
·
3 edits
MINOR
The bill underwent significant formatting cleanup and a major structural change to the board's appointment terms. The text was reorganized to remove redundant lines and consolidate definitions. Most importantly, the appointment schedule for the new Prescription Drug Pricing Board was altered to include staggered terms for initial members, followed by a standard 4-year term for subsequent members, replacing the previous specific year-by-year breakdown.
TECHNICAL
Removed multiple redundant lines containing version tracking numbers and page headers that cluttered the text.
Consolidated the definition of 'Biologic' and reorganized the layout of the definitions section for clarity.
REQUIREMENT
Changed the appointment schedule for the Prescription Drug Pricing Board from specific 1- and 2-year terms for the first batch of members to a system where initial members serve staggered terms, and all future members serve 4-year terms.
Floor votes · Senate Apr 24, 2025
How they voted
20–16
Passed · 2 other
Total votes 38
Apr 24, 2025
D
Democratic19
100% Yea
R
Republican19
84% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
17
Key actions
5
Committee
5
Amendments
2
Apr 24, 2025
Committee
referred to Committee on Government Operations
lower
Apr 24, 2025
Introduced
received on 04/24/2025
lower
Apr 24, 2025
Upper · Passed
PASSED ROLL CALL # 68 YEAS 20 NAYS 15 EXCUSED 1 NOT VOTING 1
upper
Apr 24, 2025
Upper · Passed
AMENDMENT(S) ADOPTED
upper
Apr 24, 2025
Amended
AMENDMENT(S) DEFEATED
upper
Apr 24, 2025
Upper · Passed
SUBSTITUTE (S-1) CONCURRED IN
upper
Apr 24, 2025
Upper · Passed
REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1)
upper
Apr 24, 2025
Committee
REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1)
upper
Apr 24, 2025
Upper · Passed
REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 4/23/2025
upper
Jan 8, 2025
Committee
REFERRED TO COMMITTEE ON FINANCE, INSURANCE, AND CONSUMER PROTECTION
upper
Jan 8, 2025
Introduced
INTRODUCED BY SENATOR DARRIN CAMILLERI
upper
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Darrin Camilleri
DDemocratic
Co
John Cherry
DDemocratic
Co
Stephanie Chang
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 3
Scope: MI
Hi! I can help you understand SB 3. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline